{
  "id": "16bb9953-7577-4eed-8a37-0c68b5a9eebc",
  "filename": "gut00414-0011.pdf",
  "doc_type": "pdf",
  "content": "Gut,1982,23,357-361 Pancreatic exocrinefunctioninseverehumanchronic renalfailure* COWYANG,t LJMILLER, EPDiMAGNO,t JCMITCHELL III,andVLWGO FromtheGastroenterology Unit,MayoClinicandMayoFoundation, Rochester, MN,USA SUMMARY Patients withchronicrenalfailurehaveanabnormal immunoreactive gastrointestinal hormone profile,whichischaracterised byraisedfastingserumconcentrations ofhormones that haveantagonistic effectsonexocrine pancreatic function. Inaddition, inthispresentstudywe havefoundthatinrenalinsufficiency cholecystokinin disappears slowlyfromtheplasmaaftera constant intravenous infusion ofthehormone (p=O0O5 compared withhealthysubjects). To evaluate whether thestimulatory orinhibitory hormones haveapredominant effect,pancreatic exocrine function underconditions ofmannitol perfusion oftheduodenum andcontinuous intravenous cholecystokinin stimulation wasstudiedineightpatients whohadseverechronic renalfailureandeightage-matched andsex-matched controlsubjects. Compared withhealthy subjects, patients withrenalinsufficiency hadhypersecretion oftrypsininresponse bothto mannitol perfusion oftheduodenum andtocholecystokinin stimulation (p<0-05). Nosignificant differences inlipasesecretion werenotedbetween thepatients withrenalinsufficiency and controlsubjects. Thesefindings areconsistent withthehypothesis that,oftheabnormally raised fastingserumconcentrations ofgastrointestinal hormones foundinrenalinsufficiency, hormones thatstimulate ratherthaninhibitpancreatic exocrine function predominate. Secondly, the dissociation between trypsinandlipaseoutputsinchronicrenalfailuremaysuggestadifferential trophicinfluence ofstimulatory hormones -thatis,hypercholecystokininaemia -onpancreatic exocrine enzymesecretion. Patients withchronicrenalfailurehaveanabnormal gastrointestinal hormone profile,whichischaracter- isedbyraised serumconcentrations ofcholecysto- kinin(CCK),' apowerful stimulator ofpancreatic exocrine function, aswellasinhibitors ofpancreatic secretion suchasglucagon1 2andpancreatic poly- peptide.3 Theeffectofthisabnormal hormone profile1 onpancreatic function, however, isnot known.Also,severalofthesehormones mayhave trophiceffects onthepancreas.4 Toevaluate whether thestimulators orinhibitors ofpancreatic secretion haveapredominant effect andwhether atrophiceffectofthesehormones can beshown, westudiedpancreatic enzyme secretion inresponse tomannitol perfusion oftheduodenum (control) andmaximal pancreatic enzyme secretory *Thisinvestigation wassupported inpartbyResearch GrantAM7198from theNational Institutes ofHealth, PublicHealthService,Bethesda, MD,USA. tPresent address: GIResearch Unit,University Hospital, AnnArbor,MI 48104,USA. *Address forreprintrequests: EPDiMagno, MD,Gastroenterology Unit, MayoClinic,Rochester, MN55905,USA. Received forpublication 4September 1981capacity (CCK-stimulated) inagroupofpatients withseverechronicrenalfailureandinage-matched andsex-matched normal subjects andthen measured thedisappearance ofCCKafterterminat- ingacontinuous CCKintravenous infusion. Methods SUBJECTS Eightpatients (men,aged25to62years)with severechronicrenalfailure(serumcreatinine con- centrations 12.0to16-9mg/dl,mean14.3)andeight age-matched andsex-matched controls werestudied aftergivingwritteninformed consent. Thepatients withrenalfailurewereonchronichaemodialysis programmes foratleast18monthsbeforethestudy andhadtheircareinmedicinal programme super- visedbyoneofus(JCM).Thepatientswerestudied onnon-dialysis days,whenserumionisedcalcium concentrations werenormalandnon-fluctuating. All patients weredialysed againsta075-088 mmol/l (3.0-3.5mEq/l)calciumbath,whichusuallycausesa transient (threeto12hours)increase ofserum 357 Owyang, Miller,DiMagno, Mitchell, andGo calciumconcentrations ofnomorethan0.5-075 mmol/l(1-1.5mg/100ml).Allsubjects werewithin 10%oftheiridealweight,instructed toeatanormal proteindiet,andhadnoprevious gastrointestinal or biliarysurgeryorothersignificant co-existent endo- crinopathy. Allpatients hadnormalserumconcen- trationsofglucoseandcalciumandweretakingno medication knowntointerfere withpancreatic function. PROCEDURE Pancreatic lipaseandtrypsinsecretions werestudied usingourstandard gastroduodenal intubation per- fusiontechnique.5 Tosummarise thistechnique, afteranovernight fastadouble-lumen duodenal tubeandaseparate gastricsumptubewereposi- tionedfluoroscopically sothattheduodenal per- fusionsitewasinthesecondpartoftheduodenum, theduodenal aspiration sitewas20cmdistaltothis attheligament ofTreitz,andthegastricsumptube wasinthegastricantrum. Theduodenal perfusion solution usedwasanisotonic solution ofmannitol containing anon-absorbable markerpolyethylene glycol(PEG4000)(5g/l)warmed to37°Cand adjusted topH7.0.Mannitol wasusedinthisseries ofstudiesinsteadofourusualsalineperfusate becauseofthenecessity torestrictsodiuminrenal failure.Duodenal samples werecollected atthe leveloftheligament ofTreitzbysiphonage and werepooledevery20minutes overice.Gastric contents wereaspirated fromtheantrumbycon- tinuousmechanical suction.Aftersteady-state con- ditionswereestablished, samples werecollected for twohours.Thencollections werecontinued forone hourwhilepancreatic enzymesecretion wasstimu- latedbythecontinuous intravenous infusionof20% porcine CCK(GIHLaboratory, Karolinska Institute, Stockholm) givenatarateof0-25CHR U/kg/min. Fournormalsubjectsandfiveofthepatientswith renalinsufficiency donated bloodattwo,four,seven,nine,12,15,and20minutesaftertheendof theone-hour continuous intravenous infusion of 20%porcineCCK.Ofthe7mlofperipheral venous bloodcollected, 3mlwascollected inaprotinin (Trasylol)-ethylenediaminetetra-acetate tubes,and 4mlwasallowed toclot.Thesesamples were centrifuged at44°C,andplasmaandserumwere divided intoaliquots andfrozenat-20°Cuntil assayscouldbeperformed. Cholecystokinin wasmeasured byaradio- immunoassay recentlydeveloped inourlaboratory.6Radioiodination of99%pureporcineCCK(kindly supplied byDrVMutt,Karolinska Institute, Stock- holm,Sweden) wasaccomplished byhavingthe hormone reactwithsuccinimide esterof125I-labelled3-(4-hydroxyphenyl) propionic acidaccord- ingtothenewBolton-Hunter method.7 Thespecific activitywas50,uCi/,ug.Antiserum (No3482)usedin theassaywasraisedinNewZealand rabbitsby repeated intradermal injections of20%pureporcine CCK.Itwasusedatafinaldilution of1:25000. Thisantiserum hadnosignificant cross-reactivity withhumanheptadecapeptide gastrin(G-17).The assaydetected serumCCKataconcentration of50 pg/ml.Theintra-assay andinterassay coefficient of variation forduplicate systemswaslessthan13%. Results oftheserumCCKwereexpressed in picograms permillilitre, withCCK-33 usedasthe standard. Concentrations ofpolyethylene glycol,8trypsin,9 andlipase9weremeasured inallduodenal samples. Trypsinandlipaseconcentrations weredetermined bymeansofanautomatic titration method using TAME(p-toluene sulfonyl-2-arginine methylester) andfatemulsion (Lipomul) assubstrates forthe respective enzymeactivities.9 Theenzyme outputs werecalculated, basedonrecovery ofpolyethylene glycol5andexpressed in103U/(kU)perhour. Differences between enzyme secretion during mannitol perfusion oftheduodenum andCCK- stimulated pancreatic enzyme secretion obtained frompatients withchronicrenalfailureandthose obtained fromthenormalcontrols weretestedusing Student's ttest,withp<005beingsignificant. Results TRYPSIN SECRETION Inresponse toduodenal mannitol perfusion the meanpancreatic trypsinoutputinchronic renal failureof51±10kU/h(mean±SD)wassignificantly higherthanthemeantrypsin outputof23±8 observed inhealthy controls (p<0-01) (Fig.1). Therewasnooverlap intrypsinoutputs between thesegroups. Despite thepatient's raisedtrypsinoutputs in response toduodenal mannitol perfusion andtheir raisedfastingserumCCKconcentrations,' the intravenous infusion ofexogenous porcine CCK furtherincreased thetrypsinoutputineverypatient withchronicrenalfailure(p<0-01) (Fig.1).Trypsin outputincreased fourfold afterintravenous CCK stimulation (51±10kU/hto213±108). Inthe controlgroupthetrypsinoutputincreased from 23±8kU/hto37±11withintravenous CCKstimula- tion(Fig.1).Thusthepancreatic trypsinsecretion, determined inresponse tothemaximal CCK stimulus, wasgreaterinpatients withchronicrenal failurethaninhealthycontrols (p<001). Further- more,theincrease intrypsinsecretion, expressed as apercentage ofsecretion inresponse tomannitol358 Pancreatic exocrinefunction inseverehumanchronicrenalfailure Health CRF Fig.1Pancreatic trypsinandlipaseoutputsinresponse to intraduodenal (ID)mannitolperfusion (0)andintravenous cholecystokinin (CCK)(0)inhealthandseverechronic renalfailure (CRF).Verticalcolumns represent mean standard deviation; *p<00- (chronic renalfailureID mannitol compared withhealthIDmannitol); **p<0OI (chronicrenalfailureCCKcompared withhealthCCK); kUrepresents I103units. perfusion, wasgreaterinchronicrenalfailurethan inhealth(431±263% v172±43%, p<001) (Fig.2). LIPASE SECRETION Incontrast withthehigherthannormal trypsin outputobserved inchronic renalfailurethere was nosignificant difference inlipaseoutputinresponse tomannitol perfusion between patients withchronic renalfailureandhealthycontrols (194±58 v163±46 kU/h,p>005) (Fig.1).Theintravenous infusion of porcine CCKresulted inasimilar significant increase inlipaseoutputineverypatient with chronic renalfailure(194±58 to393±95 kU/h, p<0.05) andinhealth(163±46 to307±94 kU/h, p<O0O5). LipaseoutputwithCCKadministration in 1000- 800 - Ratioof StimCCK 600- trypsinoutput Mannitol ID x100D.trypsinoutput 400*P<0.01 ExiSD 2001E0[77, 0 . Health CRF Fig.2Maximal stimulated pancreatic trypsinsecretion in response toCCKexpressed asapercentage ofthatelicited byduodenal mannitol perfusion isshownforhealthy controls andpatients withseverechronic renalfailure (CRF).Individual dataandgroup means±SDareshown; *p<O-O..chronicrenalfailurewasnotsignificantly different fromthatobserved inhealthycontrols. IMMUNOREACTIVE CCKDISAPPEARANCE STUDY Aftertheendofthecontinuous intravenous infusion of20%porcineCCK,thedisappearance ofCCK fromthebloodduringthefirstsevenminutes (Table,Fig.3)appeared tobethesamefornormal subjects andpatients withchronic renalfailure. Aftertheinitialsevenminutes, however, CCK disappearance inthepatientswithrenalfailurewas significantly slower(p=0.05; Table). Discussion Wehavepreviously shownthatthefastinggastro- intestinal immunoreactive hormones aresignifi- cantlyhigherinrenalinsufficiency compared with normalsubjects andsuggested thattheycouldalter gastrointestinal functions inthesepatients.' We havenowshownthatpatients withrenalfailurehave hypersecretion ofpancreatic trypsinbutnotlipasein response toamannitol duodenal perfusion andto intravenous infusion ofCCK.Thesefindings might beexplained bytheaugmentation oftheraised fasting serumconcentrations ofgastrointestinal hormones inwhichstimulatory hormones suchas CCKratherthaninhibitory hormones havethe predominant effect.1016Indeed, wehavefoundthat inpatients withrenalinsufficiency theplasma disappearance ofCCKisslow,andnormalfasting levels arenotachieved. Thesedataemphasise that inrenalinsufficiency thereiscontinuous CCK stimulation oftheexocrine pancreas, which may causepancreatic hypertrophy, hyperplasia, or increased sensitivity oftheacinarcellstostimulating hormones suchasCCKorgastrin orboth. Intherat41718chronic injection ofCCK increases pancreatic weightandpancreatic content ofprotein, DNA, RNAamylase, andtrypsin. Furthermore, Barrowman andMayston17 reported thatthechronicinjection ofCCKinratsresulted in astrikingincrease ofpancreatic content ofamylase TableDisappearance ofbloodduringfirst sevenminutes Patientswith Normalsubjects renalinsufficiency Slope(min) (n=4) (n=5) Oto7 -4400±1655 -3627±1580 9to20 32±12 148±70* Meanandstandard errorofthefirstsevenandlast12minutesof theCCKdisappearance curvesfornormalsubjectsandpatientswithrenalinsufficiency. Slopescalculated bylinearregression. *p=O0O5compared with9-20minutemeanvalueinthenormal subjects.Trypsin *,500- 2400- ,300- Z ,200- E N 0 CHealth CRF* * s359 360 Owyang, Miller,DiMagno, Mitchell, andGo Heclth CRF ,00o00080.000 60.000 40000 20000 100008.000 6.000 4,000 2.000 ,E._000o1800 0.600_400 200 100 80 80 40 20 10 I A 5 10 15 20 5 10 1520 Time(min) Fig.3PlasmaCCKdisappearance curvesafterendofa constant intravenous infusionofcholecystokinin forfour normalcontrolsubjects(health)andfivepatientswithsevere chronicrenalfailure(CRF). andproteolytic enzymes butnotoflipase.Ourdata, whichshowadissociation between trypsinand lipaseoutputsinpatientswithchronicrenalfailure inwhomwehaveshownhypercholecysto- kininaemia, areconsistent withthisdifferential trophicinfluence onpancreatic exocrine enzymes. Theoretically, thedifferences betweentrypsinand lipasesecretion couldbeduetoadaptation of pancreatic enzymes todietarycomposition. 19 Recently, Felberandhiscolleagues20 reported that carbohydrates, lipids,andproteins induced the preferential secretion ofamylase, lipase,ortrypsin andchymotrypsin, respectively. Ourpatients, how- ever,werereceiving anormalproteindiet.There- fore,itisunlikely thatdietarymanipulation hada majorroleininfluencing pancreatic enzyme secre- tioninourpatients.- Inourhealthysubjectstrypsinoutputinresponse toduodenal mannitol perfusion wasthreetofour timestheamountsecreted inresponse toduodenal salineperfusion'0 11butissubmaximal andthesame asthatobserved withduodenal perfusion ofan essential amino-acid mixture.10 12Thusmannitol perfusion oftheintestine probably activates a neurohormonal mechanism .thatstimulates pan- creaticsecretion, whichisaugmented inrenal failure.Similarly, intravenous infusion ofporcine CCKatadoseof0.25CHRU/kg/min produces maximal secretion ofpancreatic enzymes inhealthysubjects.1' 12Inchronicrenalfailure,however, the pancreatic trypsinsecretion inresponse tothisCCK stimulus wassignificantly greaterthaninhealthy controls. Inallotherstudiesnormalordecreased pan- creaticsecretion hasbeenfoundinchronicrenal insufficiency. Normal2' ordecreased22 23bicarbo- natesecretion inresponse tosecretinandnormal24ordecreased2' 2325CCK-stimulated amylaseoutput havebeenreported. Whentrypsin21 2325orlipase21 outputshavebeenmeasured theyhaveusuallybeen normal.Lipaseoutputs, however, werefoundtobe abnormally lowin15of25patients.25 Thatour resultsdifferfromthesestudiesmaybedueto different techniques (wemeasured outputs by recovery ofanunabsorbable marker), awareness of thepossibility ofincreased secretion, andselection ofpatients. Theclinicalimportance ofhypersecretion of pancreatic trypsininchronic renalfailureisun- certainatpresent. Noneoftheeightsubjectswhom westudiedhadexperienced atypicalepisode of pancreatitis. Ahighprevalence ofpancreatic disease inchronic renalfailure, however, hasbeen reported,26 27andinonenecropsy report27 patho- logicalchanges inthepancreas werepresentin 56.8%ofthecasesinwhichmaintenance haemo- dialysishadbeenusedbeforedeathfromuraemia. Histological changes included ductectasia, peri- ductalfibrosis, ductular proliferation, acinar ductularmetaplasia, andinterstitial fibrosis.27 Itis tempting tospeculate thatpancreatic trypsinhyper- secretion mayinitiatepancreatic diseaseinthis groupofpatients. Thesignificance ofthisfinding, however, stillawaits further clinical and pathological studies. References 1Owyang C,MillerLJ,GoVLW,DiMagno EP, Brennan LA,Jr.Thegastrointestinal hormone profile inrenalinsufficiency. MayoClinProc1979;54:769-73. 2BilbreyGL,Faloona GR,WhiteMG,Knochel JP, Borroto J.Hyperglucagonemia ofrenalfailure.JClin Invest1974;53:841-7. 3Hallgren R,Lundqvist G,ChanceRE.Serumlevelsof humanpancreatic polypeptide inrenaldisease.ScandJ Gastroenterol 1977;12:923-7. 4EnochsMR,Johnson LR.Hormonal regulation of gastrointestinal tractgrowth: biochemical andphysio- logicalaspects. In:JerzyGlassGB,ed.Progress in gastroenterology. NewYork:GruneandStratton, 1977:3-28. 5GoVLW,Hofmann AF,Summerskill WH.Simul- taneous measurements oftotalpancreatic, biliary,and gastricoutputs inmanusingaperfusion technique. Gastroenterology 1970:58:321-8. Pancreatic exocrinefunction inseverehumanchronicrenalfailure 361 6GoVLW,Owyang C.Radioimmunoassay ofgastro- intestinal hormones. In:JerzyGlassGB,ed.Progress ingastroenterology. NewYork:GruneandStratton, 1977:153-78. 7BoltonAE,HunterWM.Thelabelling ofproteins to highspecificradioactivities byconjugation toa125I containing acylating agent:application totheradio- immunoassay. Biochem J1973;133:529-39. 8HydenS.Aturbidimetric methodforthedetermina- tionofhigherpolyethylene glycols inbiological materials. KLantbrukshogsk Ann1956;22:139-45. 9PelotD,Grossman MI.Distribution andfateof pancreatic enzymes insmallintestine oftherat.AmJ Physiol1962;202:285-8. 10DiMagno EP,GoVLW,Summerskill WH.Intra- luminalandpost-absorptive effectsofaminoacidson pancreatic enzimesecretion. JLabClinMed1973;82: 241-8. 11DiMagno EP,Malagelada J-R,GoVLW.Relationship between alcoholism andpancreatic insufficiency. Ann NYAcadSci1975;252:200-7. 12DiMagno EP,GoVLW,Summerskill WH.Relations betweenpancreatic enzymeoutputsandmalabsorption inseverepancreatic insufficiency. NEnglJMed1973; 288:813-5. 13Konturek SJ,TasleyJ,Obtulowicz W.Characteristics ofinhibition ofpancreatic secretion byglucagon. Digestion 1974;10:138-49. 14LinT-M,EvansDC,ChanceRE,SprayGF.Bovine pancreatic peptide: actionongastricandpancreatic secretion indogs.AmJPhysiol1977;232:E311-5. 15BloomSR,AdrianTE,Greenberg GR,etal.Effectsof pancreatic polypeptide infusion inman(abstract). Gastroenterology 1978;74:1012.16Malagelada J-R,GoVLW,Summerskill WH.Altered pancreatic andbiliaryfunction aftervagotomy and pyloroplasty. Gastroenterology 1974;66:22-7. 17Barrowman JA,Mayston PD.Thetrophicinfluence of cholecystokinin ontheratpancreas (abstract). J Physiol(Lond)1974;238:73P-5P. 18MainzDL,Black0,Webster PD.Hormonal controlof pancreatic growth.JClinInvest1973;52:2300-4. 19Grossman MI,Greengard H,IvyAC.Onthemecha- nismoftheadaptation ofpancreatic enzymes todietary composition. AmJPhysiol1944;141:38-41. 20FelberJP,Bandule-Dick J,derKalbermatten N. Entericcontrolofthepancreas. In:BloomSR,ed.Gut hormones. Edinburgh: Churchill Livingstone, 1978: 310-3. 21OtteM,Stahlheber H,ForellMM,etal.Exokrine Pankreasfunktion beichronischer Niereninsuffizienz. KlinWochenschr 1975;53:67-72. 22BartosV,Melichar J,ErbenJ.Thefunction ofthe exocrine pancreas inchronicrenaldisease. Digestion 1970;3:33-40. 23PollVM,WernerJ,HuberW,Kempmann G,WilligF. Exokrine Pankreasfunktion beichronischer Nieren- insuffizienz. ZGastroenterol 1979;17:177-86. 24Gerhardt VW,SteinG,Bosseckert H,Graupner C, NoskeA.Exkretorische Pankreasfunktion beiNieren- insuffizienz. ZGesamte InnMed1974;29:895-9. 25WittichK-A,Schmidt H,SchelerF,Creutzfeldt W. Exokrine Pankreasfunktion beichronischer Nieren- insuffizienz. VerhDtschGesInnMed1968;74:1072-4. 26Baggenstoss AH.Thepancreas inuremia: ahisto- pathologic study.AmJ.Pathol1948;24:1033-17. 27AvramMM.Highprevalence ofpancreatic diseasein chronicrenalfailure.Nephron 1977;18:68-71.",
  "created_at": "2025-10-21T03:22:17.669871",
  "status": "completed",
  "metadata": {
    "file_path": "data\\documents\\16bb9953-7577-4eed-8a37-0c68b5a9eebc.pdf",
    "chunks_count": 41
  }
}